Filing Details
- Accession Number:
- 0001209191-20-042216
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-10 18:12:05
- Reporting Period:
- 2020-07-08
- Accepted Time:
- 2020-07-10 18:12:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1636050 | Axovant Gene Therapies Ltd. | AXGT | Pharmaceutical Preparations (2834) | 981333697 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643071 | Atul Pande | C/O Axovant Gene Therapies Ltd. 11 Times Square, 33Rd Floor New York NY 10036 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2020-07-08 | 10,000 | $2.73 | 23,370 | No | 4 | P | Indirect | By Atul C. Pande & Patricia A Pande TR DTD 08/24/2017 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Atul C. Pande & Patricia A Pande TR DTD 08/24/2017 |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.7075 to $2.73 per share, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchase at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
